Prostate Cancer (Emerging Cancer Therapeutics): 2 - Hardcover

James L. Gulley

 
9781936287468: Prostate Cancer (Emerging Cancer Therapeutics): 2

Synopsis

This issue of "Emerging Cancer Therapeutics" provides a comprehensive review for practitioners on the current status of prostate cancer treatment. Prostate cancer treatment has undergone major changes over the course of the past few years and the pace of new research and development is expected to continue at a high level for the immediate future. "Prostate Cancer" addresses current best practices in the light of the most recent evidence and new developments in this field. All of the chapters are written by international experts in the field, address the common clinical scenarios in prostate cancer and are multidisciplinary in scope. Coverage includes discussion of prevention, screening, surgery, radiation therapy, chemotherapy, immunotherapy, new therapeutic approaches, and more. This title features an editorial board of nationally recognized experts across the spectrum of Cancer Therapeutics. It includes in-depth, up-to-date expert reviews and analysis of major new developments in all areas of Cancer Therapeutics. These are issues edited by an authority in specific subject area. It focuses on major topics in Cancer Therapeutics with in-depth articles covering advances in clinical and translational research developments, as well as clinical applications and experience. It emphasizes multidisciplinary approaches to research and practice.

"synopsis" may belong to another edition of this title.

About the Author

James Gulley, MD, PhD, FACP Director, Clinical Immunotherapy Group, Senior Investigator, National Cancer Institute Jame Abraham, MD Bonnie Wells Wilson Distinguished Professor and Eminent Scholar, Chief, Section of Hematology-Oncology, Medical Director, Mary Babb Randolph Cancer Center West Virginia University

"About this title" may belong to another edition of this title.